Cipla Q2 net profit drops 35% to Rs 878 crore as revenue slips 2.4%
Cipla reported a 35% fall in Q2 FY27 net profit to Rs 877.54 crore, while revenue declined 2.4% year on year, according to TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Indian drugmaker Cipla reported that consolidated net profit for the quarter ended September 2026 fell 35% year on year, to Rs 877.54 crore from roughly Rs 1,350 crore a year earlier. The figures were published by TradingView.
Revenue from operations declined 2.4%, to Rs 7,403.93 crore from about Rs 7,586 crore in the same period last year. The drop in profit was considerably sharper than the drop in sales, pointing to pressure on margins.
On Tuesday afternoon, Cipla shares traded 1.4% lower at Rs 1,336 apiece as investors assessed the quarterly performance.
why it matters
The key takeaway is not only the revenue decline but the gap between the profit fall and the sales fall. That gap suggests higher costs or a weaker income mix, although the source does not explain the reasons. Investors in the Indian pharma sector will likely watch margins closely in upcoming reports.
market impact
Cipla shares and Indian pharma sector: weaker profit weighs on the company's stock
tags
instruments
sources
- Cipla Q2 results: Net profit plunges 35% to Rs 878 crore, revenue falls 2.4% YoY — TradingView, 27 October 2026 at 08:05 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗